SFXN2 and acute myeloid leukemia: Intriguingly, the interdependency between SFXN2 and clinical outcomes also exists in Acute Myeloid Leukemia (AML) based on the gene expression profiling data from the TCGA (http://gepia.cancer-pku.cn/detail.php?gene=sfxn2) [29].